2021 annual financial data
Recursion Pharmaceuticals 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -1,586.14%.
Operating income was -182,775,000 USD and net income was -178,074,000 USD.
Operating cash flow was -158,614,000 USD.
Get free Recursion Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,000,000 USD
- Operating income
- -182,775,000 USD
- Net income
- -178,074,000 USD
- Operating cash flow
- -158,614,000 USD